Procter & Gamble Health Q3 Results
- BSE: 500126
- NSE: PGHL
- ISIN: INE199A01012
- Sector: Biotechnology & Drugs
BSE
5,848.05
71.00 (1.23%)
71.00 (1.23%)Volume692.00
Updated: Mon 14 Jul, 2025 | 12:11:46
NSE
5,861.50106.00 (1.84%)
106.00 (1.84%)Volume10.54 K
Updated: Mon 14 Jul, 2025 | 12:17:38
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹310.99 Cr.(23.17%)
- Operating Profit₹75.55 Cr.(24.67%)
- Profit After Tax₹61.18 Cr.(31.40%)
- Operating Margin24.29%(1.21%)
Note: Comparison is on YoY basis
Quarterly - Procter & Gamble Health Q3 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 23 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 235.44 | 215.24 | 22.70% | 191.88 | 22.70% |
| Depreciation/ Amortization | 5.37 | 6.92 | -3.24% | 6.84 | -21.49% |
| Operating Income | 75.55 | 94.73 | -35.91% | 60.60 | 24.67% |
| Net Income | 61.18 | 72.07 | -32.70% | 46.56 | 31.40% |
| Other Operating Expenses Total | 82.56 | 60.50 | 29.89% | 62.72 | 31.63% |
| Net Income Before Taxes | 78.53 | 99.72 | -35.47% | 62.72 | 25.21% |
| Total Revenue | 310.99 | 309.97 | 0.39% | 252.48 | 23.17% |
| Selling/ General/ Admin Expenses Total | 48.79 | 57.43 | 3.70% | 48.46 | 0.68% |
| Diluted Normalized EPS | 36.86 | 43.40 | -32.69% | 28.00 | 31.64% |